Latest News about RHHBY
Recent news which mentions RHHBY
FDA Approves Roche's Polivy Combo Therapy For Untreated Patients With Diffuse Large B-Cell Lymphoma
April 20, 2023
From Benzinga
EXCLUSIVE: FDA Grants Expedited Review Status To SAB Biotherapeutics' Influenza Antibody
April 13, 2023
From Benzinga
Why Shares of Adaptimmune Therapeutics Jumped Tuesday
April 11, 2023
From Motley Fool
From Benzinga
From Benzinga
New Four Year Data For Roche's Evrysdi Reinforces Long-Term Efficacy, Safety Profile In Muscular Atrophy Patients
March 20, 2023
From Benzinga
Sarepta Plunges As FDA Takes Surprise Turn; AdComm Meeting Set For Duchenne Gene Therapy
March 17, 2023
From Benzinga
From Benzinga
The Top 7 Growth Stocks in Biotech
March 03, 2023
From InvestorPlace
Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo
March 03, 2023
From Benzinga
Why Sarepta Therapeutics' Shares Rose 23.4% This Week
March 02, 2023
From Motley Fool
3 Best Growth Stocks to Buy In March
March 02, 2023
From Motley Fool
Blueprint Medicines Highlights Detailed Data From Lead Product In Blood Cancer Patients
February 27, 2023
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Roche Touts Positive Crovalimab Data From Late-Stage Study In Rare Blood Condition
February 07, 2023
From Benzinga
Roche Flags Lower 2023 Sales On Declining Demand For COVID-19 Treatment, Diagnostics
February 02, 2023
From Benzinga
From Benzinga
Genentech's Tecentriq Plus Avastin Combo Cuts Risk of Cancer Returning In Early-Stage Liver Cancer
January 19, 2023
From Benzinga
Trading Volume In The OTCQB Venture Market Picks Up in December – A Summary Of OTC Market Group's Most Active List In December
January 17, 2023
From Benzinga
Europe Approves Xofluza, Roche's Revolutionary Influenza Antiviral with New Mechanism
January 12, 2023
From Benzinga
From Benzinga
From Benzinga
Better Large-Cap Buy: Roche Holding or Gilead Sciences Stock?
January 02, 2023
From Motley Fool
Roche's Follicular Lymphoma Therapy Scores FDA Approval
December 23, 2022
From Benzinga
FDA Approves Roche's Tocilizumab As First Monoclonal Antibody For COVID-19 Treatment
December 22, 2022
From Benzinga
Gilead Sciences (GILD) Stock Falls on Lung Cancer Drug Data
December 20, 2022
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.